Yi Hee Jung, Hong Kyung Sook, Moon Nara, Chung Soon Sup, Lee Ryung-Ah, Kim Kwang Ho
Department of Surgery, Ewha Womans University School of Medicine, Seoul, Korea.
Ann Surg Treat Res. 2016 Mar;90(3):179-82. doi: 10.4174/astr.2016.90.3.179. Epub 2016 Feb 26.
5-Fluorouracil (5-FU) based chemotherapy has been commonly used to treat metastatic or advanced colon cancer as an adjuvant chemotherapy. Although the side effects of 5-FU such as gastrointestinal problems and neutropenia and thrombocytopenia are common, not many cases of 5-FU related encephalopathy are reported. Hyperammonemic encephalopathy is a rare central nervous system toxicity following 5-FU chemotherapy manifesting as altered mental status with elevated ammonia levels with no radiologic abnormality. We report one case of 5-FU induced hyperammonemic encephalopathy occurring after Folfox4 (oxaliplatin, folinic acid and 5-fluorouracil) chemotherapy in a colon cancer patient who presented with confused mental status soon after the chemotherapy and review the 5-FU related encephalopathy.
基于5-氟尿嘧啶(5-FU)的化疗作为辅助化疗已被广泛用于治疗转移性或晚期结肠癌。尽管5-FU的副作用如胃肠道问题、中性粒细胞减少和血小板减少很常见,但5-FU相关脑病的报道并不多。高氨血症性脑病是5-FU化疗后罕见的中枢神经系统毒性,表现为精神状态改变,血氨水平升高,且无影像学异常。我们报告1例结肠癌患者在接受Folfox4(奥沙利铂、亚叶酸和5-氟尿嘧啶)化疗后发生5-FU诱导的高氨血症性脑病,该患者在化疗后不久出现精神状态混乱,并对5-FU相关脑病进行了综述。